BriaCell Therapeutics(BCTX)
$3.59-0.10 (-2.71%)
BCTX
BriaCell Therapeutics financials statements
$3.59
At close:-0.10 (-2.71%)
BriaCell Therapeutics (BCTX) Financial Statements
336 Followers
BriaCell Therapeutics Financial Overview
BriaCell Therapeutics's market cap is currently C$31.86M. The company's EPS TTM is C$-9.32; its P/E ratio is -0.38; BriaCell Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jul 26 | Jul 25 | Jul 24 | Jul 23 | Jul 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ -121.09K | C$ -107.93K | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Operating Income | C$ -36.58M | C$ -27.54M | C$ -33.33M | C$ -23.27M | C$ -15.29M |
| EBITDA | C$ -36.46M | C$ -27.43M | C$ -4.85M | C$ -23.26M | C$ -26.82M |
| Net Income | C$ -35.42M | C$ -26.63M | C$ -4.79M | C$ -20.30M | C$ -26.84M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 20.53M | C$ 17.93M | C$ 862.09K | C$ 21.25M | C$ 41.04M |
| Total Assets | C$ 23.57M | C$ 21.72M | C$ 5.87M | C$ 27.16M | C$ 42.58M |
| Total Debt | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Net Debt | C$ -9.85M | C$ -10.53M | C$ -862.09K | C$ -21.25M | C$ -41.04M |
| Total Liabilities | C$ 8.02M | C$ 4.33M | C$ 8.56M | C$ 30.94M | C$ 32.25M |
| Stockholders' Equity | C$ 16.39M | C$ 17.94M | C$ -2.38M | C$ -3.78M | C$ 10.33M |
| Cash Flow | |||||
| Free Cash Flow | C$ -29.20M | C$ -28.51M | C$ -24.58M | C$ -23.74M | C$ -12.48M |
| Operating Cash Flow | C$ -29.07M | C$ -28.51M | C$ -24.13M | C$ -23.74M | C$ -12.48M |
| Investing Cash Flow | C$ -3.86M | C$ -7.74M | C$ -681.80K | C$ 0.00 | C$ 0.00 |
| Financing Cash Flow | C$ 32.28M | C$ 46.00M | C$ 4.42M | C$ 3.95M | C$ -3.74M |
Currency in CAD
